Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
He says the decision for a company to commercialize a single-dose vial versus a pre-filled syringe, multi-dose vial, or multi-dose auto-injector is complicated and always well thought out
Your prescribing doctor may recommend semaglutide to improve glucose control in type 2 diabetes or to support weight management in people with obesity
You might qualify if you meet one of these main criteria: A body mass index (BMI) of 30 kg/m or higher A BMI of 27 kg/m or higher with at least one weight-related health condition Health conditions that support your eligibility include: High blood pressure Type 2 diabetes High cholesterol Heart disease Sleep apnea The FDA expanded semaglutides approval in March 2024
According to FDA sources, empagliflozin supports glycemic control and has approved cardiovascular and kidneyrelated uses, while liraglutide treats type 2 diabetes and reduces cardiovascular risk in certain adults
